|
AstraZeneca Pharma India in collaboration with STEMI India announces the launch of India Coronary Conquest (ICC) 2026, a clinician led, national Complex PCI challenge that connects early to mid-career interventional cardiologists. Through real world case presentations and transparent, peer reviewed critique, ICC focuses on intravascular imaging and physiology, guideline aligned decision making, complication management, and procedural safety to strengthen everyday practice.
In India, one in four people is likely to die of a chronic disease. Driven by a shared ambition to enhance care for people living with cardiovascular, renal and metabolic conditions, AstraZeneca is supporting ICC to advance evidence based education in complex percutaneous coronary intervention (PCI).
“In advancing science, we must also empower the people who deliver it. India Coronary Conquest embodies AstraZeneca’s purpose, to push the boundaries of science to deliver life changing medicines and our education first commitment to cardiovascular care in India. By combining real world case learning with transparent peer review from leading operators, accelerates the adoption of complex PCI coupled with intravascular imaging and interventional techniques in line with vascular physiology and evidence-based guidelines. It reinforces our belief in integrity led, clinician owned education and strengthens sustainable capacity building across diverse care settings,” said Dr Sandeep Arora, director, medical affairs, AstraZeneca Pharma India.
At the core of ICC is its faculty of 30 Course Principals- distinguished interventional cardiologists who mentor participants and adjudicate cases with scientific independence. The lineup includes Dr A B Mehta, Jaslok Hospital, Mumbai, Prof Dr D S Gambhir, group director, Kailash Hospital, Noida, Prof Dr Kamal Sharma, senior interventional cardiologist, SAL Hospital, Ahmedabad as Course Principal and Scientific Lead, among others. The programme has already attracted more than 120 complex PCI case submissions from across India, underscoring strong demand for rigorous, case based learning.
“ICC is a movement to elevate cardiac care. By taking this exchange fully virtual, high level expertise in complex PCI becomes accessible nationwide, accelerating evidence adoption and better outcomes," said Prof Dr Kamal Sharma, course principal and scientific lead- ICC.
Prof Dr Akshaya Pradhan, faculty, Department of Cardiology, King George's Medical University said, “By pairing seasoned operators with emerging specialists, we can push the boundaries of cardiovascular care through mentorship and innovation.”
|